The once-daily oral drug is intended to enhance the effects of donepezil (Pfizer and Eisai’s off-patent Aricept), with pivotal trial results expected in October this year. This will be easier to ...

Jan 13 (Reuters) - U.S. drugmaker Pfizer (PFE.N), opens new tab is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive ...